13D/13G Filings - Cogent Biosciences Inc. (COGT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-11
6:28 pm
Sale
2024-09-30 13G Cogent Biosciences, Inc.
COGT
Venrock Healthcare Capital Partners II, L.P. 6,446,917
5.800%
-5,069,750decrease
(-44.02%)
Filing
History
2025-02-14
4:10 pm
Sale
2024-12-31 13G Cogent Biosciences, Inc.
COGT
Point72 Asset Management, L.P. 9,986,132
8.700%
-5,130,364decrease
(-33.94%)
Filing
History
2025-02-12
4:35 pm
Purchase
2025-02-05 13G Cogent Biosciences, Inc.
COGT
Paradigm BioCapital Advisors LP 5,559,924
5.000%
5,559,924increase
(New Position)
Filing
History
2025-02-12
09:28 am
Purchase
2024-12-31 13G Cogent Biosciences, Inc.
COGT
FMR CORP 16,569,256
15.000%
3,360,284increase
(+25.44%)
Filing
History
2024-11-14
7:59 pm
Purchase
2024-09-30 13G Cogent Biosciences, Inc.
COGT
Point72 Asset Management, L.P. 15,116,496
9.900%
9,872,873increase
(+188.28%)
Filing
History
2024-11-14
5:47 pm
Purchase
2024-09-30 13G Cogent Biosciences, Inc.
COGT
Venrock Healthcare Capital Partners II, L.P. 11,516,667
9.990%
2,477,823increase
(+27.41%)
Filing
History
2024-11-14
4:05 pm
Purchase
2024-09-30 13G Cogent Biosciences, Inc.
COGT
Commodore Capital LP 10,497,990
9.300%
4,325,904increase
(+70.09%)
Filing
History
2024-11-14
3:52 pm
Sale
2024-09-30 13G Cogent Biosciences, Inc.
COGT
SUVRETTA CAPITAL MANAGEMENT, LLC 0
0.000%
-5,481,034decrease
(Position Closed)
Filing
History
2024-11-14
12:24 pm
Purchase
2024-09-30 13G Cogent Biosciences, Inc.
COGT
Kynam Capital Management, LP 9,239,731
8.360%
3,384,965increase
(+57.82%)
Filing
History
2024-11-07
09:24 am
Purchase
2024-11-06 13G Cogent Biosciences, Inc.
COGT
FMR CORP 13,208,972
12.068%
4,889,561increase
(+58.77%)
Filing
History
2024-11-07
09:12 am
Purchase
2024-11-06 13G Cogent Biosciences, Inc.
COGT
FMR CORP 8,319,411
7.601%
3,016,557increase
(+56.89%)
Filing
History
2024-06-13
06:06 am
Purchase
2024-06-11 13D Cogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC 11,330,141
9.900%
1,343,585increase
(+13.45%)
Filing
History
2024-04-01
6:30 pm
Sale
2024-03-28 13D Cogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC 9,986,556
9.900%
-31,519decrease
(-0.31%)
Filing
History
2024-03-27
4:37 pm
Sale
2024-03-25 13D Cogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC 10,018,075
9.900%
-13,061,066decrease
(-56.59%)
Filing
History
2024-02-16
6:55 pm
Purchase
2024-02-16 13D Cogent Biosciences, Inc.
COGT
Fairmount Funds Management LLC 23,079,141
18.890%
3,116,577increase
(+15.61%)
Filing
History
2024-02-14
8:33 pm
Purchase
2023-12-31 13G Cogent Biosciences, Inc.
COGT
Venrock Healthcare Capital Partners II, L.P. 9,038,844
9.990%
1,729,716increase
(+23.67%)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-31 13G Cogent Biosciences, Inc.
COGT
RA Capital Management, L.P. 0
0.000%
-5,999,481decrease
(Position Closed)
Filing
History
2024-02-14
4:11 pm
Purchase
2023-12-31 13G Cogent Biosciences, Inc.
COGT
Point72 Asset Management, L.P. 5,243,623
6.100%
1,680,721increase
(+47.17%)
Filing
History
2024-02-14
4:05 pm
Purchase
2023-12-31 13G Cogent Biosciences, Inc.
COGT
Commodore Capital LP 6,172,086
7.100%
1,246,086increase
(+25.30%)
Filing
History
2024-02-14
12:51 pm
Purchase
2023-12-31 13G Cogent Biosciences, Inc.
COGT
Kynam Capital Management, LP 5,854,766
6.800%
5,854,766increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, Next